Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MYCA: Myocet and Carboplatin in Relapsed Platinum-Sensitive Ovarian Cancer
NCT01705158Phase 2Completed
- Sponsor
- ARCAGY
- Start
- Oct 2012
- Primary completion
- Oct 2014
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 2 trial of pegylated liposomal doxorubicin in ovarian cancer, sponsored by ARCAGY. Started Oct 2012; status: completed.
02
Drugs
pegylated liposomal doxorubicin
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT01705158.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01705158.